Drug-drug interaction study of RDEA806 and emtricitabine/tenofovir disoproxil fumarate [Truvada].

Trial Profile

Drug-drug interaction study of RDEA806 and emtricitabine/tenofovir disoproxil fumarate [Truvada].

Not stated
Phase of Trial: Phase I

Latest Information Update: 14 Nov 2008

At a glance

  • Drugs RDEA 806 (Primary) ; Emtricitabine/tenofovir disoproxil fumarate
  • Indications HIV infections
  • Focus Pharmacokinetics
  • Sponsors Ardea Biosciences
  • Most Recent Events

    • 14 Nov 2008 New trial record.
    • 14 Nov 2008 Preliminary data has been presented at the 48th ICAAC/IDSA 46th Annual Meeting, according to an Ardea Biosciences media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top